Doctors Praise New Cancer Vaccine from Moderna and Merck
Specialists celebrate new data showing Moderna and Merck's cancer shot helps melanoma patients stay healthy after surgery.
Doctors see fresh hope for skin cancer patients. A new treatment from Moderna and Merck trains the body to fight melanoma after surgery. Medical experts call the trial results a major step forward.
Six cancer specialists reviewed the latest study data. They say the personalized shot lowers the chance that the disease returns. Wall Street reacted with caution, but doctors stand firmly behind the science.
The shot pairs Moderna's mRNA technology with Merck's cancer drug Keytruda. Each treatment targets the specific tumor cells of a single patient. This design helps the immune system clear out leftover cancer cells.
Medical breakthroughs often take time to win over investors. For patients and families, these results prove that cancer care is improving.
Source: CNBC
More from Biotech
